1. Home
  2. KYMR vs SHOO Comparison

KYMR vs SHOO Comparison

Compare KYMR & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • SHOO
  • Stock Information
  • Founded
  • KYMR 2015
  • SHOO 1990
  • Country
  • KYMR United States
  • SHOO United States
  • Employees
  • KYMR N/A
  • SHOO N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • SHOO Shoe Manufacturing
  • Sector
  • KYMR Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • KYMR 3.0B
  • SHOO 3.1B
  • IPO Year
  • KYMR 2020
  • SHOO 1993
  • Fundamental
  • Price
  • KYMR $41.96
  • SHOO $43.23
  • Analyst Decision
  • KYMR Buy
  • SHOO Hold
  • Analyst Count
  • KYMR 13
  • SHOO 8
  • Target Price
  • KYMR $51.15
  • SHOO $45.38
  • AVG Volume (30 Days)
  • KYMR 415.6K
  • SHOO 816.2K
  • Earning Date
  • KYMR 10-31-2024
  • SHOO 11-07-2024
  • Dividend Yield
  • KYMR N/A
  • SHOO 1.94%
  • EPS Growth
  • KYMR N/A
  • SHOO 6.16
  • EPS
  • KYMR N/A
  • SHOO 2.36
  • Revenue
  • KYMR $87,563,000.00
  • SHOO $2,220,323,000.00
  • Revenue This Year
  • KYMR N/A
  • SHOO $15.16
  • Revenue Next Year
  • KYMR $21.47
  • SHOO $5.30
  • P/E Ratio
  • KYMR N/A
  • SHOO $18.35
  • Revenue Growth
  • KYMR 86.92
  • SHOO 14.89
  • 52 Week Low
  • KYMR $17.89
  • SHOO $36.23
  • 52 Week High
  • KYMR $53.27
  • SHOO $50.01
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 34.56
  • SHOO 35.28
  • Support Level
  • KYMR $45.16
  • SHOO $43.18
  • Resistance Level
  • KYMR $53.23
  • SHOO $45.51
  • Average True Range (ATR)
  • KYMR 2.58
  • SHOO 1.38
  • MACD
  • KYMR -0.54
  • SHOO -0.14
  • Stochastic Oscillator
  • KYMR 1.66
  • SHOO 2.59

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: